tiprankstipranks
Repare Therapeutics Inc (RPTX)
NASDAQ:RPTX
US Market
Holding RPTX?
Track your performance easily

Repare Therapeutics (RPTX) Financial Statements

370 Followers

Repare Therapeutics Financial Overview

Repare Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.995; its P/E ratio is -1.56; Repare Therapeutics is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.83. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue--$ 52.40M$ 13.05M$ 2.16M
Gross Profit-----
EBIT$ -33.92M$ -34.45M$ 10.82M$ -30.87M$ -38.42M
EBITDA$ -32.76M$ -31.58M$ 11.32M$ -30.36M$ -37.92M
Net Income Common Stockholders$ -34.41M$ -34.77M$ 13.16M$ -28.03M$ -18.88M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 179.43M$ 208.12M$ 237.00M$ 223.63M$ 250.07M
Total Assets$ 206.39M$ 235.34M$ 263.08M$ 253.90M$ 286.41M
Total Debt$ 2.56M$ 2.17M$ 2.78M$ 3.41M$ 3.92M
Net Debt$ -176.87M$ -205.95M$ -234.22M$ -220.22M$ -246.15M
Total Liabilities$ 31.43M$ 31.67M$ 31.13M$ 41.82M$ 53.04M
Stockholders Equity$ 174.96M$ 203.68M$ 231.95M$ 212.08M$ 233.37M
Cash Flow-
Free Cash Flow$ -30.54M$ -30.51M$ 11.93M$ -28.55M$ -32.87M
Operating Cash Flow$ -30.54M$ -30.51M$ 11.93M$ -28.16M$ -32.87M
Investing Cash Flow$ 31.08M$ 7.12M$ -20.32M$ 31.88M$ 24.50M
Financing Cash Flow$ 166.00K-$ 375.00K$ 105.00K$ 284.00K
Currency in USD

Repare Therapeutics Earnings and Revenue History

Repare Therapeutics Debt to Assets

Repare Therapeutics Cash Flow

Repare Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis